SCHEMBL19680296

SCHEMBL19680296

CCOC(=O)c1cnn2c(C)c(C)c(Cl)nc12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 10/20 0.55
HSD17B10 Q99714 7/20 0.55
ALDH1A1 P00352 7/20 0.55
HPGD P15428 6/20 0.55
NPC1 O15118 5/20 0.55
RAB9A P51151 5/20 0.55
SMN1; SMN2 Q16637 4/20 0.55
LMNA P02545 1/20 0.51
POLB P06746 1/20 0.51
CCNA2 P20248 1/20 0.51
CDK2 P24941 1/20 0.51
MAPT P10636 3/20 0.50
CASP1 P29466 3/20 0.50
CASP7 P55210 2/20 0.50
NFKB1 P19838 1/20 0.50
NFKB2 Q00653 1/20 0.50
RELA Q04206 1/20 0.50
TSHR P16473 1/20 0.50
CSNK1D P48730 2/20 0.48
GAA P10253 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17781277 0.89 KDM4E (0.53) KDM4EHSD17B10ALDH1A1HPGDNPC1
SCHEMBL20697060 0.87 KDM4E (0.64) KDM4EHSD17B10ALDH1A1HPGDNPC1
SCHEMBL19680294 0.86 KDM4E (0.57) KDM4EHSD17B10ALDH1A1HPGDNPC1
SCHEMBL19680290 0.85 KDM4E (0.56) KDM4EHSD17B10ALDH1A1HPGDNPC1
SCHEMBL19680289 0.84 KDM4E (0.55) KDM4EHSD17B10ALDH1A1HPGDRAB9A
SCHEMBL25117830 0.82 ALDH1A1 (0.62) KDM4EHSD17B10ALDH1A1HPGDNPC1
SCHEMBL22105271 0.82 KDM4E (0.54) KDM4EHSD17B10ALDH1A1HPGDNPC1
SCHEMBL21961701 0.81 KDM4E (0.50) KDM4EHSD17B10ALDH1A1HPGDNPC1
SCHEMBL25117794 0.80 ALDH1A1 (0.60) KDM4EHSD17B10ALDH1A1HPGDNPC1
SCHEMBL12756120 0.79 KDM4E (0.48) KDM4EHSD17B10ALDH1A1HPGDNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9840510-B1 Pyrazolo[1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders LYSOSOMAL THERAPEUTICS INC. (US) 2017-12-12 US disclosed
US-20170349598-A1 PYRAZOLO[1,5-A]PYRIMIDINYL CARBOXAMIDE COMPOUNDS AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS BIAL - R&D INVESTMENTS, S.A. (PT) 2017-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170349598-A1 PYRAZOLO[1,5-A]PYRIMIDINYL CARBOXAMIDE COMPOUNDS AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS GBA1, GAA, PARK7 KDM4E 690/4885HSD17B10 4115/4885ALDH1A1 1104/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.